Wahana Interfood Nusantara
COCO
$69.37
-6.82%
The Vita Coco Company is a plant-based functional hydration platform, best known for its flagship Vita Coco Coconut Water, and also offers private label coconut products and other brands like Runa and Ever & Ever. As the dominant player in the coconut water category, it holds a strong competitive position in the non-alcoholic beverage industry, leveraging a differentiated natural hydration proposition. The current investor narrative centers on accelerating revenue growth driven by expanding distribution, product innovation, and international expansion, with recent quarterly results showing a 37% YoY revenue surge that has reignited interest in the stock's growth trajectory and margin expansion potential.…
COCO
Wahana Interfood Nusantara
$69.37
COCO 12-Month Price Forecast
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Wahana Interfood Nusantara's 12-month outlook, with a consensus price target around $77.22 and implied upside of +11.3% versus the current price.
Average Target
$77.22
0 analysts
Implied Upside
+11.3%
vs. current price
Analyst Count
—
covering this stock
Price Range
$65 - $85
Analyst target range
COCO is covered by 9 analysts, with a consensus recommendation of 'Buy' (mean rating of 1.64 on a 1-5 scale where 1 is Strong Buy). The average target price is $76.67, implying a modest 2.6% upside from the current price of $74.75. The distribution shows 5 Buy ratings, 3 Hold, and 1 Sell, indicating a generally bullish but not overly enthusiastic consensus. The target range spans from a low of $65.00 to a high of $85.00. The high target of $85.00 assumes continued strong growth and potential multiple expansion, while the low target of $65.00 factors in risks such as competition or margin compression. The spread of $20 (26% of the average target) suggests moderate uncertainty. Recent rating actions are positive: Stephens upgraded from Equal Weight to Overweight in November 2025, and BofA upgraded from Neutral to Buy in the same month, indicating improving sentiment among analysts.
Bulls vs Bears: COCO Investment Factors
COCO presents a compelling growth story with accelerating revenue, expanding margins, and a pristine balance sheet. The bull case is supported by strong fundamental momentum and market outperformance. However, the stock trades at a significant premium to the beverage industry, and analyst targets suggest limited near-term upside. The single most important tension is whether the company can sustain its 37% revenue growth rate; if it does, the premium valuation may be justified, but any deceleration could trigger multiple compression and a sharp correction.
Bullish
- Revenue Growth Accelerating Sharply: Q1 2026 revenue grew 37.3% YoY to $179.8M, up from 13.4% growth in Q1 2025, indicating strong market share gains and consumer demand for functional hydration.
- Expanding Profit Margins: Gross margin improved to 39.7% in Q1 2026 from 36.6% a year ago, while net margin expanded to 17.0% from 14.4%, driven by favorable product mix and operating leverage.
- Fortress Balance Sheet: The company has $203.2M in cash, no interest expense, and a debt-to-equity ratio of just 0.045, providing ample liquidity to fund growth without external financing.
- Strong Relative Performance: COCO has outperformed the S&P 500 by 75.6% over the past year, with a 96.6% total return versus the index's 20.9%, reflecting strong investor conviction.
Bearish
- Premium Valuation vs. Peers: Trailing P/E of 42.4x is 93% above the beverage industry average of ~22x, leaving little room for error if growth decelerates.
- Limited Analyst Upside: The average analyst target of $76.67 implies only 2.6% upside from the current price of $74.75, suggesting the stock is fairly valued near-term.
- Recent Price Pullback: The stock has declined 9.8% in the past month from its 52-week high of $85.83, indicating potential profit-taking or waning momentum.
- Concentration Risk in Coconut Water: Vita Coco Coconut Water represents the vast majority of revenue, with limited diversification from other brands like Runa and Ever & Ever, making the company vulnerable to category shifts.
COCO Technical Analysis
COCO is in a strong uptrend, with the stock up 96.6% over the past year, significantly outperforming the S&P 500's 20.9% gain. The current price of $74.75 sits at 87% of its 52-week range ($31.79-$85.83), indicating the stock is near the upper end of its range and reflecting robust momentum. This positioning suggests the market is pricing in continued positive fundamentals, though it also implies limited near-term upside from a pure technical breakout perspective unless new catalysts emerge. Short-term momentum shows a mixed picture: the 1-month change is -9.8%, while the 3-month change is +54.6%. The 1-month pullback from the June high of $84.02 to the current $74.75 represents a correction of about 11%, which could be a healthy consolidation within the broader uptrend. The divergence between the 1-month decline and the strong 3-month and 1-year gains suggests a temporary pullback rather than a trend reversal, especially given the stock's relative strength versus the S&P 500 (1-month relative strength of -10.4% but 3-month relative strength of +48.4%). Key support lies at the 52-week low of $31.79, but more immediate support is around $66 (the July low), while resistance is at the 52-week high of $85.83. A breakout above $85.83 would signal a continuation of the uptrend, while a breakdown below $66 could indicate a deeper correction. The stock's beta of 0.764 indicates it is less volatile than the overall market, meaning it tends to move less than the S&P 500, which may appeal to risk-averse investors but also means it may lag during strong market rallies.
Beta
0.76
0.76x market volatility
Max Drawdown
-23.2%
Largest decline past year
52-Week Range
$32-$86
Price range past year
Annual Return
+81.5%
Cumulative gain past year
| Period | COCO Return | S&P 500 |
|---|---|---|
| 1m | -16.2% | +0.6% |
| 3m | +37.7% | +3.4% |
| 6m | +32.6% | +7.1% |
| 1y | +81.5% | +16.4% |
| ytd | +29.8% | +8.3% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
COCO Fundamental Analysis
Revenue growth has accelerated sharply, with Q1 2026 revenue of $179.8 million representing a 37.3% YoY increase, up from 13.4% growth in Q1 2025. The trailing twelve-month revenue run rate is approximately $659 million, driven by strong performance in the Vita Coco Coconut Water segment ($140.6 million in Q1 2026) and private label ($33.2 million). This acceleration is a key positive for the investment case, suggesting the brand is gaining market share and benefiting from increased consumer demand for functional hydration. Profitability is solid and improving: Q1 2026 net income was $30.5 million, up from $18.9 million in the prior year quarter, with net margin expanding to 17.0% from 14.4%. Gross margin improved to 39.7% from 36.6% a year ago, driven by favorable product mix and cost efficiencies. Operating margin also rose to 18.7% from 14.7%, indicating strong operating leverage as revenue scales. The company has a fortress balance sheet with no interest expense, $203.2 million in cash, and a debt-to-equity ratio of just 0.045. Free cash flow was $15.1 million in Q1 2026, though TTM free cash flow of $64.5 million represents a free cash flow yield of about 2.1% at the current market cap. ROE stands at 21.5%, reflecting efficient capital use, and the current ratio of 3.62 indicates ample liquidity to fund growth internally without relying on external financing.
Quarterly Revenue
$179765000.0B
2026-03
Revenue YoY Growth
+37.3%
YoY Comparison
Gross Margin
39.7%
Latest Quarter
Free Cash Flow
$64523000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is COCO Overvalued?
Since net income is positive, the primary valuation metric is the P/E ratio. The trailing P/E is 42.4x, while the forward P/E is 36.1x, implying the market expects earnings growth of about 17% over the next year. The gap between trailing and forward P/E suggests that while the stock is not cheap, the market is pricing in continued earnings expansion. Compared to the beverage industry average P/E of approximately 22x (based on sector data), COCO trades at a 93% premium. This premium is partially justified by the company's superior revenue growth (37% vs. industry average of ~5-10%) and expanding margins, but it also leaves little room for error. Historically, COCO's trailing P/E has ranged from about 14x to 155x over the past five years. The current 42.4x is near the middle of that range but above the median of around 24x. This suggests the stock is not at extreme valuation levels but is priced for above-average growth, which could lead to multiple compression if growth disappoints.
PE
42.4x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 15x~56x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
30.1x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: COCO's high valuation (trailing P/E 42.4x) implies aggressive growth expectations. If revenue growth decelerates from the current 37% YoY, the stock could face multiple compression. The company has no debt and ample cash, so balance sheet risk is minimal, but its free cash flow yield of 2.1% is low, meaning the stock is priced for perfection. Additionally, gross margin at 39.7% is below some beverage peers, and any input cost inflation could pressure profitability.
Market & Competitive Risks: The stock's beta of 0.764 suggests lower market correlation, but its premium valuation makes it vulnerable to sector rotation away from growth stocks. The beverage industry is highly competitive, with large players like Coca-Cola and PepsiCo potentially entering the coconut water space. Regulatory risks around health claims or labeling could also impact the category. The recent 9.8% one-month pullback highlights the stock's sensitivity to sentiment shifts.
Worst-Case Scenario: If revenue growth disappoints (e.g., falls below 15%) due to competition or market saturation, the stock could re-rate to a P/E more in line with the industry average of 22x. Applying that multiple to forward EPS of $2.07 (estimated) yields a target of ~$45.50, representing a 39% decline from the current price of $74.75. The 52-week low of $31.79 implies a potential 57% downside in a severe downturn.